Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Promega; Sigma-Aldrich; HistoRx; Med fusion

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Promega this week said that its Maxwell 16 IVD System has been CE Marked in Europe. The CE Mark applies to the Maxwell 16 Blood DNA Purification System and the Maxwell 16 Viral Total Nucleic Acid Purification System. Promega said that the system supports clinical labs performing diagnostic tests in molecular pathology, transplant HLA, and infectious disease.

Sigma-Aldrich this week said that it has signed an agreement to acquire Ace Animals, a provider of research rodents. The firm said that the acquisition will enhance its portfolio of next-generation knockout and knockin rat models that have specific gene deletions, insertions, repressions, and modifications created using its CompoZr zinc finger nuclease technology. Terms of the acquisition were not disclosed.

HistoRx has received a loan of $1.5 million from Connecticut Innovations, which the Rocky Hill, CT.-based firm will use to build out its lab space and purchase equipment. HistoRx's Aqua technology quantifies specific protein expression within different parts of the cell within cancerous tissue samples. The firm is providing the technology to biotech and pharmaceutical firms as an aid in determining which drugs may be best suited to a particular patient's cancer. Connecticut Innovations is the state's quasi-public authority for technology investing and innovation development.

Med fusion, a new clinical lab and clinical trials services firm, will begin operations this spring, the firm announced Thursday. Med fusion is a collaboration between the Baylor Health Care System, Texas Oncology, Pathologists Biomedical Laboratories, and US Oncology. Among its services will be pathology testing and molecular diagnostics, the Dallas-based firm said. Med fusion intends to hire 320 employees next year and have more than 900 employees by 2014.

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.